45 CFR § 180 compliance
B · 85
This hospital published most of what § 180 requires.
●Machine-readable file published
●Gross / standard charges
●Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
1,838
Insurances with rates
44
CPT / HCPCS codes
0
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| 191 | CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH CC | $41,252 | $26,814 | — | — | 65 |
| 560 | AFTERCARE, MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITH CC | $25,056 | $16,287 | — | — | 64 |
| 949 | AFTERCARE WITH CC/MCC | $20,746 | $13,485 | — | — | 64 |
| 202 | BRONCHITIS AND ASTHMA WITH CC/MCC | $20,699 | $13,454 | — | — | 64 |
| 559 | AFTERCARE, MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITH MCC | $20,500 | $13,325 | — | — | 64 |
| 440 | DISORDERS OF PANCREAS EXCEPT MALIGNANCY WITHOUT CC/MCC | $18,248 | $11,861 | — | — | 65 |
| 639 | DIABETES WITHOUT CC/MCC | $18,239 | $11,855 | — | — | 64 |
| 392 | ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MCC | $17,096 | $11,113 | — | — | 65 |
| 309 | CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH CC | $16,743 | $10,883 | — | — | 65 |
| 190 | CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH MCC | $16,356 | $10,631 | — | — | 65 |
| 439 | DISORDERS OF PANCREAS EXCEPT MALIGNANCY WITH CC | $16,213 | $10,538 | — | — | 65 |
| 603 | CELLULITIS WITHOUT MCC | $14,825 | $9,636 | — | — | 64 |
| 192 | CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITHOUT CC/MCC | $14,298 | $9,294 | — | — | 65 |
| RX-79456 | ALTEPLASE 50 MG INTRAVENOUS SOLUTION | $13,641 | $8,866 | — | — | 111 |
| CASE-69100 | Biopsy External Ear | $13,134 | $8,537 | — | — | 13 |
| RX-129357 | DARBEPOETIN ALFA 500 MCG/ML IN POLYSORBATE INJECTION SYRINGE | $11,997 | $7,798 | — | — | 111 |
| 896 | ALCOHOL, DRUG ABUSE OR DEPENDENCE WITHOUT REHABILITATION THERAPY WITH MCC | $11,894 | $7,731 | — | — | 65 |
| 897 | ALCOHOL, DRUG ABUSE OR DEPENDENCE WITHOUT REHABILITATION THERAPY WITHOUT MCC | $11,865 | $7,712 | — | — | 65 |
| 074 | CRANIAL AND PERIPHERAL NERVE DISORDERS WITHOUT MCC | $11,726 | $7,622 | — | — | 65 |
| PX-500002349 | Excise Tumor Soft Tiss Back or Flank 3cm/> | $11,650 | $7,573 | — | — | 93 |
| PX-350007468 | Excise Excess Skin & Tissue Other Area | $11,009 | $7,156 | — | — | 110 |
| 158 | DENTAL AND ORAL DISEASES WITH CC | $10,433 | $6,782 | — | — | 65 |
| RX-178388 | BENDAMUSTINE 100 MG INTRAVENOUS POWDER FOR SOLUTION | $10,411 | $6,767 | — | — | 111 |
| RX-80554 | CROTALIDAE POLYVAL IMMUNE FAB 1 GRAM SOLUTION FOR INJECTION | $9,914 | $6,444 | — | — | 103 |
| SUP-98000800209 | CMNT KNEE 2 - MERCY CAP 98000800209 | $8,570 | $5,571 | — | — | 99 |
| 310 | CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITHOUT CC/MCC | $8,060 | $5,239 | — | — | 65 |
| 561 | AFTERCARE, MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITHOUT CC/MCC | $7,342 | $4,773 | — | — | 64 |
| SUP-98000800208 | CMNT KNEE 1 - MERCY CAP 98000800208 | $7,040 | $4,576 | — | — | 99 |
| CASE-36416 | Capillary Blood Specimen Collect | $6,780 | $4,407 | — | — | 12 |
| RX-190284 | DENOSUMAB 60 MG/ML SUBCUTANEOUS SYRINGE|RX AMT DISCARD/NOT ADMIN TO PT | $6,564 | $4,267 | — | — | 111 |
| RX-253476 | DENOSUMAB-BNHT 60 MG/ML SUBCUTANEOUS SYRINGE | $6,377 | $4,145 | — | — | 102 |
| RX-253466 | DENOSUMAB-BMWO 60 MG/ML SUBCUTANEOUS SYRINGE|RX AMT DISCARD/NOT ADMIN TO PT | $6,236 | $4,053 | — | — | 102 |
| CASE-46200 | Fissurectomy Incl Sphincterotomy When Performed | $6,128 | $3,983 | — | — | 13 |
| CASE-45398 | Colonoscopy W/Band Ligation(S) Pf | $5,805 | $3,774 | — | — | 13 |
| RX-182466 | FERUMOXYTOL 510 MG/17 ML (30 MG/ML) INTRAVENOUS SOLUTION | $5,670 | $3,685 | — | — | 103 |
| CASE-99285 | ED Visit Care Level 5 | $5,623 | $3,655 | — | — | 18 |
| RX-253077 | DENOSUMAB-BBDZ 60 MG/ML SUBCUTANEOUS SYRINGE|RX AMT DISCARD/NOT ADMIN TO PT | $5,614 | $3,649 | — | — | 102 |
| PX-700001393 | CT Abd Pelvis WO Cont Then W Cont | $5,594 | $3,636 | — | — | 111 |
| RX-209792 | DALBAVANCIN 500 MG INTRAVENOUS SOLUTION | $5,515 | $3,585 | — | — | 111 |
| PX-350002721 | Exc Lesion Tend Sheath or Capsule Toe Ea | $5,350 | $3,478 | — | — | 110 |
| PX-700001412 | Cta Abd Pelvis Wwo Contrast | $4,963 | $3,226 | — | — | 111 |
| RX-129718 | DARBEPOETIN ALFA 200 MCG/0.4 ML IN POLYSORBATE INJECTION SYRINGE | $4,799 | $3,119 | — | — | 111 |
| CASE-88311 | Decalcification Procedure | $4,545 | $2,954 | — | — | 13 |
| PX-350001955 | Amputation Toe Partial | $4,418 | $2,872 | — | — | 110 |
| PX-350001940 | Exc Ben Les Sc/Nk/Hds 0.5/<Cm | $4,250 | $2,763 | — | — | 110 |
| CASE-45172 | Exc Rct Tum Incl Muscularis Propria | $4,121 | $2,679 | — | — | 13 |
| PX-700001392 | CT Abd Pelvis With Contrast | $4,105 | $2,668 | — | — | 111 |
| RX-300910 | ALTEPLASE 1 MG/ML IV SOLUTION | $4,092 | $2,660 | — | — | 111 |
| PX-350002394 | Colectomy Partial W Anastomosis Pf | $3,929 | $2,554 | — | — | 111 |
| PX-700002250 | Cta Head&Neck +Cont W/Noncontrast Img | $3,915 | $2,545 | — | — | 102 |
Showing top 50 of 1,838 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.